AGRX's Market share relative to its competitors, as of Q2 2024

As of Q2 2024 (Revenue in Millions of $)

Date modified: 2025-05-15T08:34:00+00:00

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Market Share▼

COMPANY NAME	REVENUES 12 Months Ending Q2 2024	MARKET SHARE 12 Months Q2 2024	MARKET SHARE MRQ Q2 2024	MARKET SHARE A Quarter Before Q1 2024
Agile Therapeutics Inc	19.72	0.02%	0.02 %	0.02 %
Eli Lilly And Company	49,003.20	39.82%	40.64%	41.77%
Amgen Inc	33,424.00	27.16%	29.01%	26.24%
Teva Pharmaceutical Industries Limited	16,617.00	13.50%	12.42%	13.06%
Viatris Inc	14,330.20	11.64%	10.39%	10.89%
Perrigo Company Plc	4,334.30	3.52%	3.33%	3.52%
Amneal Pharmaceuticals Inc	2,868.80	2.33%	2.22%	2.51%
Avalara Inc.	789.43	0.64%	0.67%	0.63%
Harmony Biosciences Holdings inc	743.53	0.60%	0.59%	0.62%
Myovant Sciences Ltd	379.11	0.31%	0.32%	0.32%
Mannkind Corporation	297.60	0.24%	0.25%	0.24%
Puma Biotechnology Inc	232.71	0.19%	0.15%	0.18%
Allarity Therapeutics Inc	23.79	0.02%	0.00%	0.00%
Immuron Limited	1.48	0.00%	0.00%	0.00%
Therapeuticsmd Inc	1.41	0.00%	0.00%	0.00%
Medicinova Inc	0.00	0.00%	0.00%	0.00%
Biophytis Sa	0.00	0.00%	0.00%	0.00%
SUBTOTAL	123,066.28	100%	31,320.76	100%

AGRX's Market share relative to its competitors, as of Q2 2024 within the Major Pharmaceutical Preparations Industry

As of Q2 2024

COMPANY NAME	MARKET SHARE 12 Months Ending Q2 2024	MARKET SHARE 12 Months Ending Q1 2024	MARKET SHARE MRQ Q2 2024	MARKET SHARE Q1 2024
Agile Therapeutics Inc	0.02%	0.02%	0.02 %	0.02 %
Eli Lilly And Company	55.15%	52.93%	57.79%	57.12%
Teva Pharmaceutical Industries Limited	18.70%	19.44%	17.67%	17.86%
Viatris Inc	16.13%	17.32%	14.77%	14.89%
Perrigo Company Plc	4.88%	5.14%	4.74%	4.81%
Amneal Pharmaceuticals Inc	3.23%	3.28%	3.15%	3.43%
Harmony Biosciences Holdings inc	0.84%	0.84%	0.83%	0.85%
Myovant Sciences Ltd	0.43%	0.39%	0.46%	0.44%
Mannkind Corporation	0.33%	0.34%	0.36%	0.32%
Puma Biotechnology Inc	0.26%	0.27%	0.21%	0.25%
Allarity Therapeutics Inc	0.03%	0.03%	0.00%	0.00%
Immuron Limited	0.00%	0.00%	0.00%	0.00%
Therapeuticsmd Inc	0.00%	0.00%	0.00%	0.00%
Medicinova Inc	0.00%	0.00%	0.00%	0.00%
Biophytis Sa	0.00%	0.00%	0.00%	0.00%
SUBTOTAL	100%	100%	100%	100%

AGRX's Market share relative to its competitors, as of Q2 2024 within the Healthcare Sector

As of Q2 2024

COMPANY NAME	MARKET SHARE 12 Months Ending Q2 2024	MARKET SHARE 12 Months Ending Q1 2024	MARKET SHARE MRQ Q2 2024	MARKET SHARE Q1 2024
Agile Therapeutics Inc	0.02%	0.02%	0.02 %	0.02 %
Eli Lilly And Company	40.08%	38.29%	40.91%	42.03%
Amgen Inc	27.33%	27.66%	29.20%	26.41%
Teva Pharmaceutical Industries Limited	13.59%	14.06%	12.51%	13.14%
Viatris Inc	11.72%	12.53%	10.46%	10.96%
Perrigo Company Plc	3.54%	3.72%	3.35%	3.54%
Amneal Pharmaceuticals Inc	2.35%	2.37%	2.23%	2.53%
Harmony Biosciences Holdings inc	0.61%	0.61%	0.59%	0.63%
Myovant Sciences Ltd	0.31%	0.28%	0.32%	0.33%
Mannkind Corporation	0.24%	0.24%	0.25%	0.24%
Puma Biotechnology Inc	0.19%	0.20%	0.15%	0.18%
Allarity Therapeutics Inc	0.02%	0.02%	0.00%	0.00%
Immuron Limited	0.00%	0.00%	0.00%	0.00%
Therapeuticsmd Inc	0.00%	0.00%	0.00%	0.00%
Medicinova Inc	0.00%	0.00%	0.00%	0.00%
Biophytis Sa	0.00%	0.00%	0.00%	0.00%
SUBTOTAL	100%	100%	100%	100%

Note: Market share is calculated based on total revenue. To get a more accurate picture of Agile Therapeutics Inc's market divisions, geographic dispersion, segments, products, and services, visit Agile Therapeutics Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com